Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Parkinson disease

New guidelines for diagnosis of Parkinson disease

At least 10% of diagnoses of Parkinson disease that are made while the patient is alive are not confirmed at autopsy. To help address this issue, the European Federation of Neurology and the Movement Disorder Society European Section have provided evidence-based guidelines and recommendations for clinical diagnosis of Parkinson disease.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Hughes, A. J., Daniel, S. E., Ben-Shlomo, Y. & Lees, A. J. The accuracy of diagnosis of parkinsonian syndromes in a specialized movement disorder service. Brain 125, 861–870 (2002).

    Article  Google Scholar 

  2. Schrag, A., Ben-Shlomo, Y. & Quinn, N. How valid is the clinical diagnosis of Parkinson's disease in the community? J. Neurol. Neurosurg. Psychiatry 73, 529–534 (2002).

    Article  CAS  Google Scholar 

  3. Berardelli A. et al. EFNS/MDS-ES recommendations for the diagnosis of Parkinson's disease. Eur. J. Neurol. 20, 16–34 (2013).

    Article  CAS  Google Scholar 

  4. Brainin, M. et al. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces—revised recommendation 2004. Eur. J. Neurol. 11, 577–581 (2004).

    Article  CAS  Google Scholar 

  5. Lees, A. J., Hardy, J. & Revesz, T. Parkinson's disease. Lancet 373, 2055–2066 (2009).

    Article  CAS  Google Scholar 

  6. National Collaborating Centre for Chronic Conditions. Parkinson's Disease: National Clinical Guideline for Management in Primary and Secondary Care (Royal College of Physicians, London, 2006).

  7. Tolosa, E. & Pont-Sunyer, C. Progress in defining the premotor phase of Parkinson's disease. J. Neurol. Sci. 310, 4–8 (2011).

    Article  Google Scholar 

  8. Leone, M. A. et al. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces—revised recommendations 2012. Eur. J. Neurol. 20, 410–419 (2013).

    Article  CAS  Google Scholar 

  9. Wu, Y., Weidong, L. & Jankovic, J. Preclinical biomarkers of Parkinson disease. Arch. Neurol. 68, 22–30 (2011).

    PubMed  Google Scholar 

Download references

Acknowledgements

E. Tolosa is the Principal Investigator of Grant PI041639 from The Michael J. Fox Foundation for Parkinson Disease.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eduardo Tolosa.

Ethics declarations

Competing interests

E. Tolosa has been a consultant to Boehringer Ingelheim, Novartis, UCB, GSK, Teva and Lundbeck. He has received honoraria for speaking from Boehringer Ingelheim, Novartis, UCB, Solvay, Teva and Lundbeck. M. J. Martí declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Martí, M., Tolosa, E. New guidelines for diagnosis of Parkinson disease. Nat Rev Neurol 9, 190–191 (2013). https://doi.org/10.1038/nrneurol.2013.47

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2013.47

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing